Vitalik Buterin recently discussed the advantages of centralized L2 sequencers. The risks of centralized sequencing include ...

Illumina, Inc. (NASDAQ: ILMN) has unveiled a series of roadmap innovations, establishing the industry's largest portfolio of ...

Volta Labs, a leading genomics applications company, today announced its four strategic focus areas for 2025 and the expansion of the Callisto App menu to include RNA library prep and single-cell prep ...

Commercial launch of UG 100 Solaris which includes new chemistry, software, and simplified workflows for the UG 100 sequencing platform, now with expanded applications support and integration with ...

One of the most influential bassists of the ‘80s, Peter Hook developed a style marked by open-string drones, and a dark, ...

Vitalik Buterin explains a pathway where on-chain upgrades and efficient second-layer methods together support a more ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

Genomic sequencing remains a relatively early stage market, and expanding sequencing indications, including the nascent liquid biopsy applications that would use its sequencers, create large growth ...

Illumina is one of Mainboard-listed Venture Corporation’s major customers. Illumina’s shares have fallen some 26.4% over the ...

House Bill 327, sponsored by State Rep. Gino Bulso, R-Brentwood, will permanently designate June as Celebration of Life Month ...